The Role of Neuroimaging in the Diagnosis and Treatment of Depressive Disorder: A Recent Review

E-ISSN： 1873-4286|24|22|2515-2523

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.24, Iss.22, 2018-06, pp. : 2515-2523

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in Nutrition for the Treatment of Depressive Disorder

Current Pharmaceutical Design, Vol. 24, Iss. 22, 2018-06 ,pp. : 2583-2590

Bentham Science Publishers

Access to resources Recommend Favorite

Major Depressive Disorder and Magnetic Resonance Imaging: A Mini-Review of Recent Progress

Current Pharmaceutical Design, Vol. 24, Iss. 22, 2018-06 ,pp. : 2524-2529

Bentham Science Publishers

Access to resources Recommend Favorite

Structural Neuroimaging Findings in Major Depressive Disorder Throughout Aging: A Critical Systematic Review of Prospective Studies

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 10, 2014-12 ,pp. : 1846-1859

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Levomilnacipran in the Management of Major Depressive Disorder: A Comprehensive Review

Current Neuropharmacology, Vol. 14, Iss. 2, 2016-02 ,pp. : 191-199

Bentham Science Publishers

Access to resources Recommend Favorite

Duloxetine: A Review of its Use in the Treatment of Major Depressive Disorder

By Frampton James E. Plosker Greg L.

CNS Drugs, Vol. 21, Iss. 7, 2007-01 ,pp. : 581-609

Adis International

Access to resources Recommend Favorite